Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved
09 janv. 2018 07h00 HE
|
Midatech Pharma PLC
9 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech receives confirmation that its Q-Octreotide (MTD201) first in-human EU study is approved Midatech (AIM: MTPH,...
Midatech Loan Agreement with MidCap Financial
02 janv. 2018 07h00 HE
|
Midatech Pharma PLC
2 January 2018Midatech Pharma PLC("Midatech" or the "Company") Midatech enters into a Loan Agreement with MidCap Financial Midatech (AIM: MTPH, Nasdaq: MTP), the international...
Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients
20 déc. 2017 07h01 HE
|
Midatech Pharma PLC
Midatech Pharma PLC("Midatech" or the "Company") Midatech Pharma US initiates Gelclair® Phase IV trial to study oral mucositis in stem cell transplant patients Trial to be conducted at the...
Midatech Pharma Plc: Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly
04 sept. 2017 07h00 HE
|
Midatech Pharma PLC
4 September 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly Midatech on track to start...
Midatech Pharma Plc: Completion of pre-clinical liver cancer programme
26 juil. 2017 07h00 HE
|
Midatech Pharma PLC
26 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Completion of pre-clinical liver cancer programme Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty...
Midatech Pharma Plc: Trading Update and Notice of Results
18 juil. 2017 07h00 HE
|
Midatech Pharma PLC
18 July 2017Midatech Pharma PLC("Midatech", "Company" or "Group") Trading Update and Notice of Results Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical...
R&D manufacturing site visit for investors and analysts
13 juin 2017 07h42 HE
|
Midatech Pharma PLC
Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, is hosting a site visit today at its...
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers
07 juin 2017 11h15 HE
|
Midatech Pharma PLC
Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products in oncology, today announces that it has signed a global...
Midatech Pharma PLC: Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility
10 mars 2017 07h51 HE
|
Midatech Pharma PLC
Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility ~ Q-Octreotide will become Midatech's first Sustained Release product candidate manufactured in house at...
Midatech Pharma PLC: Trading Update
20 janv. 2017 08h02 HE
|
Midatech Pharma PLC
Midatech Pharma PLC("Midatech", "Company" or "Group") Trading Update Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and...